Jacob Hughes
Stock Analyst at Wells Fargo
(1.41)
# 3,130
Out of 4,818 analysts
27
Total ratings
50%
Success rate
-1.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jacob Hughes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals | Maintains: Equal-Weight | $40 → $44 | $23.58 | +86.60% | 5 | May 17, 2023 | |
| PRGO Perrigo Company | Upgrades: Overweight | $54 | $24.74 | +118.27% | 1 | Sep 6, 2022 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Equal-Weight | $12 → $13 | $0.77 | +1,580.46% | 3 | Aug 16, 2022 | |
| MDWD MediWound | Maintains: Overweight | $49 → $56 | $17.93 | +212.33% | 1 | May 18, 2022 | |
| EBS Emergent BioSolutions | Maintains: Equal-Weight | $46 → $38 | $5.01 | +658.48% | 3 | May 4, 2022 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Equal-Weight | $12 → $11 | $14.29 | -23.02% | 11 | Jul 29, 2021 | |
| BHC Bausch Health Companies | Maintains: Equal-Weight | $18 → $17 | $5.17 | +228.82% | 3 | Oct 28, 2020 |
Amphastar Pharmaceuticals
May 17, 2023
Maintains: Equal-Weight
Price Target: $40 → $44
Current: $23.58
Upside: +86.60%
Perrigo Company
Sep 6, 2022
Upgrades: Overweight
Price Target: $54
Current: $24.74
Upside: +118.27%
Ironwood Pharmaceuticals
Aug 16, 2022
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $0.77
Upside: +1,580.46%
MediWound
May 18, 2022
Maintains: Overweight
Price Target: $49 → $56
Current: $17.93
Upside: +212.33%
Emergent BioSolutions
May 4, 2022
Maintains: Equal-Weight
Price Target: $46 → $38
Current: $5.01
Upside: +658.48%
Teva Pharmaceutical Industries
Jul 29, 2021
Maintains: Equal-Weight
Price Target: $12 → $11
Current: $14.29
Upside: -23.02%
Bausch Health Companies
Oct 28, 2020
Maintains: Equal-Weight
Price Target: $18 → $17
Current: $5.17
Upside: +228.82%